$2.35T
Total marketcap
$108.67B
Total volume
BTC 50.74%     ETH 15.62%
Dominance

Carmat SA ALCAR.PA Stock

3.87 EUR {{ price }} -0.386601% {{change_pct}}%
COUNTRY
France
Exchange
Paris
Market Cap
112.78M EUR
LOW - HIGH [24H]
3.84 - 3.9 EUR
VOLUME [24H]
23.71K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-2.22 EUR

Carmat SA Price Chart

Carmat SA ALCAR.PA Financial and Trading Overview

Carmat SA stock price 3.87 EUR
Previous Close 7.74 EUR
Open 7.8 EUR
Bid N/A x N/A
Ask N/A x N/A
Day's Range 7.8 - 7.92 EUR
52 Week Range 7.04 - 15.59 EUR
Volume 9.3K EUR
Avg. Volume 25.17K EUR
Market Cap 182.94M EUR
Beta (5Y Monthly) 0.929206
PE Ratio (TTM) N/A
EPS (TTM) -2.22 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 24.9 EUR

ALCAR.PA Valuation Measures

Enterprise Value 177.34M EUR
Trailing P/E N/A
Forward P/E -3.371795
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 383.5152
Price/Book (mrq) 10.852819
Enterprise Value/Revenue 371.774
Enterprise Value/EBITDA -3.525

Trading Information

Carmat SA Stock Price History

Beta (5Y Monthly) 0.929206
52-Week Change -25.36%
S&P500 52-Week Change 20.43%
52 Week High 15.59 EUR
52 Week Low 7.04 EUR
50-Day Moving Average 8.08 EUR
200-Day Moving Average 10.61 EUR

ALCAR.PA Share Statistics

Avg. Volume (3 month) 25.17K EUR
Avg. Daily Volume (10-Days) 21.94K EUR
Shares Outstanding 22.68M
Float 12.61M
Short Ratio N/A
% Held by Insiders 42.92%
% Held by Institutions 2.29%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -10885.11%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.057%
Return on Equity (ttm) -615.82%

Income Statement

Revenue (ttm) 477K EUR
Revenue Per Share (ttm) 0.02 EUR
Quarterly Revenue Growth (yoy) -84.29%
Gross Profit (ttm) 300K EUR
EBITDA -50309000 EUR
Net Income Avi to Common (ttm) -53681000 EUR
Diluted EPS (ttm) -2.32
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 51.43M EUR
Total Cash Per Share (mrq) 2.27 EUR
Total Debt (mrq) 55.36M EUR
Total Debt/Equity (mrq) 335.99 EUR
Current Ratio (mrq) 4.996
Book Value Per Share (mrq) 0.727

Cash Flow Statement

Operating Cash Flow (ttm) -54375000 EUR
Levered Free Cash Flow (ttm) -39709752 EUR

Profile of Carmat SA

Country France
State N/A
City Vélizy-Villacoublay
Address 36, avenue de l'Europe
ZIP 78140
Phone 33 1 39 45 64 50
Website https://www.carmatsa.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 179

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Q&A For Carmat SA Stock

What is a current ALCAR.PA stock price?

Carmat SA ALCAR.PA stock price today per share is 3.87 EUR.

How to purchase Carmat SA stock?

You can buy ALCAR.PA shares on the Paris exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Carmat SA?

The stock symbol or ticker of Carmat SA is ALCAR.PA.

Which industry does the Carmat SA company belong to?

The Carmat SA industry is Medical Devices.

How many shares does Carmat SA have in circulation?

The max supply of Carmat SA shares is 29.18M.

What is Carmat SA Price to Earnings Ratio (PE Ratio)?

Carmat SA PE Ratio is now.

What was Carmat SA earnings per share over the trailing 12 months (TTM)?

Carmat SA EPS is -2.22 EUR over the trailing 12 months.

Which sector does the Carmat SA company belong to?

The Carmat SA sector is Healthcare.